BlackRock Institutional Trust’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$13.9M Buy
740,681
+1,828
+0.2% +$31.1K ﹤0.01% 2212
2016
Q3
$12.2M Buy
738,853
+2,078
+0.3% +$30.8K ﹤0.01% 2222
2016
Q2
$9.9M Buy
736,775
+42,473
+6% +$620K ﹤0.01% 2294
2016
Q1
$10.6M Sell
694,302
-1,045
-0.2% -$16.4K ﹤0.01% 2224
2015
Q4
$13.8M Buy
695,347
+15,665
+2% +$298K ﹤0.01% 2112
2015
Q3
$11.8M Sell
679,682
-49,513
-7% -$1.01M ﹤0.01% 2174
2015
Q2
$14.7M Sell
729,195
-38,392
-5% -$741K ﹤0.01% 2130
2015
Q1
$13.5M Buy
767,587
+6,382
+0.8% +$109K ﹤0.01% 2196
2014
Q4
$12.4M Buy
761,205
+20,637
+3% +$379K ﹤0.01% 2244
2014
Q3
$16.3M Buy
740,568
+8,023
+1% +$164K ﹤0.01% 2006
2014
Q2
$14.7M Sell
732,545
-7,374
-1% -$125K ﹤0.01% 2171
2014
Q1
$13.8M Sell
739,919
-646,766
-47% -$8.91M ﹤0.01% 2212
2013
Q4
$14M Buy
1,386,685
+552,001
+66% +$6.67M ﹤0.01% 2181
2013
Q3
$10.8M Sell
834,684
-238,055
-22% -$2.93M ﹤0.01% 2315
2013
Q2
$12.7M Buy
+1,072,739
New +$11.6M ﹤0.01% 2156

Other funds holding AMRI

BlackRock Institutional Trust's AMRI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Albany Molecular Research Inc (AMRI) stake by 0.25% in Q4 2016, buying an estimated $31.1K and bringing the position to 740,681 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

BlackRock Institutional Trust first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. The position peaked at $16.3M in Q3 2014. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • BlackRock Institutional Trust held 740,681 shares of Albany Molecular Research Inc worth $13.9M as of Q4 2016.
  • BlackRock Institutional Trust bought 1,828 Albany Molecular Research Inc shares in Q4 2016, an estimated $31.1K.
  • Albany Molecular Research Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2212 holding.
  • BlackRock Institutional Trust first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Albany Molecular Research Inc position peaked at $16.3M in Q3 2014.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.